Cervical Cancer Test Kit

Simultaneous detection and identification of 28 HPV types (19 high-risk and 9 low-risk)

Anyplex™Ⅱ HPV28 Detection simultaneously detects, differentiates and quantifies 28 distinct HPV genotypes (19 high-risk and 9 low-risk) responsible for cervical cancer and/or sexually transmitted infections. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this multiplex assay performs on real-time PCR instrument and provides high sensitivity and specificity genotyping information of infected 28 HPV types in a single reaction

KEY FEATURES AND BENEFITS

Multiplex real-time PCR
Detection and identification of 19 high-risk HPV and 9 low-risk HPV in a single reaction

Automatic data analyzer
Automated data interpretation and LIS interlocking with Seegene Viewer

Informative assay
Assistant of appropriate treatment and management for co-infection

Whole process validation
Whole process validation from extraction to PCR by whole process control

Useful monitoring
Useful tool for surveillance and infection control

User-friendly workflow
Convenient workflow using Seegene’s automated one platform

Quantitative analysis
Quantitative analysis by cyclic-CMTA

UDG system
Utilization of the UDG system to prevent carry-over contamination

Powerful performance with unique technology
Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies